ORIC Pharmaceuticals Inc
ORIC Pharmaceuticals is seeking an experienced analytical research and development scientist to join its CMC group and provide analytical leadership on projects aimed at bringing new therapeutics to cancer patients. The role involves managing outsourced and in-house research activities, leading analytical method development and validation, and overseeing GMP manufacturing and product characterization at external partners. This position requires strong cross-functional collaboration and expertise in regulatory filings and technical reporting.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2014
ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies that target cancer resistance mechanisms. The company's pipeline includes rinzimetostat and enozertinib, which are being evaluated in clinical trials for cancers such as prostate cancer and non-small cell lung cancer (NSCLC). ORIC's resistance platform addresses innate, acquired, and bypass resistance to improve the efficacy and duration of existing cancer treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ORIC Pharmaceuticals Inc.
25% above the average for this role
Senior Scientist, Analytical Sciences
Korro Bio
Senior Manager or Associate Director, Analytical Development
GSK plc
Director/Senior Director of Analytical
Systimmune
Senior CMC Specialist, Analytical
Genmab
Senior Scientist, Analytical Chemistry
Arrowhead Pharmaceuticals
Senior Director, Analytical Sciences
Verrica Pharmaceuticals